机译:胆道癌症中化疗疗效的预后免疫组织化学生物标志物:系统评价和荟萃分析
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Fac Med Dept Med Oncol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Pathol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Surg Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Surg Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Pathol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Med Oncol Amsterdam Netherlands;
Biliary tract neoplasms; Cholangiocarcinoma; Gemcitabine; Biomarkers; Human equilibrative nucleoside transporter 1 hENT1; Ribonucleotide reductase Ml; Excision repair cross-complementation I;
机译:胆道癌症中化疗疗效的预后免疫组织化学生物标志物:系统评价和荟萃分析
机译:切除的肝外胆道癌的预后分子标志物;免疫组化检测到的生物标志物的系统评价和荟萃分析
机译:一线化疗中加入分子靶向药物治疗晚期胆道癌的疗效和毒性:系统评价和荟萃分析
机译:室内日光浴和发展非慢性癌的风险:系统评价和荟萃分析
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:一线化疗中加入分子靶向药物治疗晚期胆道癌的疗效和毒性:系统评价和荟萃分析
机译:将分子靶向剂添加到一线化疗治疗晚期胆道癌症中的疗效和毒性:系统评价和荟萃分析